Thongsricome Thana, Kanjanabuch Talerngsak, Maeboonruen Nopparat, Pavatung Preeyarat, Katavetin Pisut, Eiam-Ong Somchai
Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Thailand.
Center of Excellence in Kidney Metabolic Disorders, Faculty of Medicine, Chulalongkorn University, Thailand.
Med Mycol Case Rep. 2020 Dec;30:26-28. doi: 10.1016/j.mmcr.2020.09.006. Epub 2020 Oct 1.
We reported the first clinical use of lyticase enzyme in salvaging the peritoneal dialysis (PD) catheter obstruction from fungal biofilm during the COVID-19 pandemic era with an impressive result in PD patient presenting with fungal peritonitis and ultrafiltration failure. The organism species was disclosed from PD effluent and catheter cultures. Adjuvant treatment with in-situ lyticase may be considered for catheter salvage therapy if the catheter could not promptly removed in time.
我们报告了在新冠疫情期间首次临床使用溶菌酶挽救因真菌生物膜导致的腹膜透析(PD)导管阻塞的情况,对于出现真菌性腹膜炎和超滤失败的PD患者取得了令人瞩目的效果。从PD流出液和导管培养物中发现了病原体种类。如果导管不能及时拔除,可考虑采用原位溶菌酶辅助治疗进行导管挽救治疗。